Analyzing the current literature, it was revealed that NRF2/KEAP1 signaling pathway can be modulated by natural and synthetic compounds (see Table 1 and Table 2) in both in vivo and in vitro models of prostate cancer. Here, NFE2L2 is linked to prostate carcinoma.